From Bio Co (377220) Fair Value & Analysis
Consumer Defensive · KR · Market cap 22.6B KRW
Fair value as of: Jul 9, 2026
From 1 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from 5,445 KRW to 663.28 KRW (−87.8%) since Jun 24, 2026. Share price −20.8% over the past month.
Price vs Fair Value (12 months)
12‑month range 574.82 KRW – 2,294 KRW · fair‑value band 494.99 KRW – 989.97 KRW · the 580.00 KRW price screens below the 663.28 KRW fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
From Bio Co (377220) currently trades at 580.00 KRW, while our model-based Fair Value estimate is 663.28 KRW — implying the stock looks roughly 14.4% undervalued today. We read business quality at 30/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, From Bio Co generated revenue of 72.8B KRW at a net margin of -32.1%. Revenue grew 3.6% year over year. It earns a return on equity of -69.8%. Net debt stands at 32.8B KRW. Fundamentals as of Jul 9, 2026
Our scenario range runs from 494.99 KRW (bear case) to 989.97 KRW (bull case); at 580.00 KRW, the current price sits within that range. The share trades about 75% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -27% fair-value upside — at 14%, 377220 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
From Bio Co reported revenue of 72.2B KRW in FY2025 versus 135B KRW in FY2021, a compound −14.5%/yr. Reported net income was −22.5B KRW in FY2025.
Is 377220 fairly valued? → Check now
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $97.58 | $65.41 | -33% |
| Nestlé India Limited NESTLEIND | ₹1,438 | ₹362.37 | -75% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 45.03 MXN | -21% |
| Uni-President Enterprises Corp 1216 | 75.60 TWD | 55.53 TWD | -27% |
| Britannia Industries Limited BRITANNIA | ₹5,218 | ₹3,567 | -32% |
| Tata Consumer Products Limited TATACONSUM | ₹1,131 | ₹339.05 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,250 IDR | 10,177 IDR | +63% |
| Samyang Foods Co 003230 | 1,000,000 KRW | 1,010,543 KRW | +1% |
| PT Indofood Sukses Makmur Tbk INDF | 6,725 IDR | 25,554 IDR | +280% |
| Patanjali Foods Limited PATANJALI | ₹420.45 | ₹294.68 | -30% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is From Bio Co (377220) undervalued?
What is the fair value of 377220?
What is the quality score of 377220?
What is the revenue of From Bio Co (377220)?
What is the net profit margin of 377220?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.